Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic smart Pens & Other Diabetes Products Revenue ($M) ($M)
MiniMed Group Form 10-K/10-Q Disaggregated Revenue & Sept 2026 Investor Presentation
Latest, FY2026
46
Period ended Apr 30, 2026
Change on a year earlier
+666.7%
6 in FY2025
History
4 years
Since FY2023
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Smart Pens & Other Diabetes Products Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 46 | +666.7% | MiniMed Group Investor Presentation (September 2026) ↗ |
| FY2025 | Apr 30, 2025 | 6 | -82.4% | MiniMed Group Investor Presentation (September 2026) ↗ |
| FY2024 | Apr 30, 2024 | 34 | -32.0% | MiniMed Group (MMED) 424B4 — ipo_424b4 (filed 2026-03-06) ↗ |
| FY2023 | Apr 30, 2023 | 50 | – | MiniMed Group (MMED) 424B4 — ipo_424b4 (filed 2026-03-06) ↗ |
Cite this data
StockData. (2026). Medtronic Smart Pens & Other Diabetes Products Revenue ($M) ($M), annual FY2023–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/diab-prod-other
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.